Mar 31, 2020
ESSA Pharma Submits IND for EPI-7386 for Prostate Cancer and Provides Business Update
Mar 26, 2020
COSMEDIX Announces the Launch of Clean, Clinical Spot Treatment for Acne-Prone Skin
Feb 18, 2020
Foamix Announces Integrated Efficacy Results from the FMX103 1.5% Topical Minocycline Foam Phase 3 Program for Rosacea
Feb 11, 2020
Dermata Therapeutics Announces Completion of Enrollment in a Phase 2b Trial of Once Weekly Topical Application of DMT310 for the Treatment of Moderate to Severe Acne Vulgaris
Jan 14, 2020
Foamix Announces AMZEEQ(TM) (minocycline) Achievement of Preferred Status on Express Scripts National Preferred Formulary, One of the Largest Commercial Formularies in the U.S.
Jan 13, 2020
Ortho Dermatologics Announces Publication Of Pivotal Phase 3 Data On ARAZLO(TM) (tazarotene) Lotion, 0.045% In The Journal Of Drugs In Dermatology (JDD)
Jan 09, 2020
Foamix Announces AMZEEQ(TM) (minocycline) Topical Foam Available in Pharmacies Nationwide on January 13th for the Treatment of Moderate to Severe Acne
Dec 19, 2019
FDA Approves Ortho Dermatologics' ARAZLOTM (Tazarotene) Lotion, 0.045%, For Acne Vulgaris
Dec 06, 2019
Global Acne Drugs (Salicylic acid, Retin-A Micro, Onexton, and Solodyn) Market Report 2020
Nov 04, 2019
Foamix Announces Publication of AMZEEQ(TM) (minocycline) Topical Foam Long Term Safety Data for Treatment Up to 1 Year in Journal of Clinical and Aesthetic Dermatology
Oct 25, 2019
Sebacia Reports New Long-Term Real-World Results Demonstrating 92% Average Improvement in Acne at 24 Months
Oct 18, 2019
Foamix Receives FDA Approval of AMZEEQ(TM) Topical Minocycline Treatment for Millions of Moderate to Severe Acne Sufferers
Oct 15, 2019
Bausch Health's Ortho Dermatologics Business To Present Data At The Fall Clinical Dermatology Conference
Oct 10, 2019
Foamix to Present Data on its Topical Product Candidates for Acne, Rosacea at 39th Annual Fall Clinical Dermatology Conference
Oct 04, 2019
Galderma Receives FDA Approval for AKLIEF® (trifarotene) Cream, 0.005%, the First New Retinoid Molecule for the Treatment of Acne in Over 20 Years
Aug 21, 2019
U.S. FDA Grants XTANDI® (enzalutamide) Application Priority Review for the Treatment of Men with Metastatic Hormone-Sensitive Prostate Cancer
Aug 14, 2019
ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Third Quarter Ended June 30, 2019
Aug 06, 2019
Global Acne (Medication and Therapeutic Devices) Treatment Market 2019-2023 - Key Players are Foamix Pharmaceuticals, Bausch Health Companies, Nestle and Allergan
Jun 19, 2019
Global Acne Market Spotlight 2017-2018 & 2019-2026 - ResearchAndMarkets.com
May 23, 2019
European Union Benzoyl Peroxide and Benzoyl Chloride Markets, 2013-2017 & 2018-2023 - ResearchAndMarkets.com